PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsprimary ovarian insufficiency
MeSH D016649 - primary ovarian insufficiency
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010049:Ovarian diseases
0 Companies
0 Drugs
Success rate
D016649: 
Primary ovarian insufficiency
64 Companies
24 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
67%
2/3
Phase 2
30%
3/10
Phase 3
75%
6/8
Approved: 4Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Elagolix,
Estradiol,
Estradiol benzoate,
Estradiol valerate
Agile Therapeutics
Ethinyl estradiol,
Levonorgestrel
Allergan
Estradiol,
Estradiol benzoate,
Estradiol valerate,
Norethindrone,
Norgestrel,
Testosterone,
Testosterone enanthate,
Testosterone undecanoate
Amneal Pharmaceuticals
Estradiol,
Estradiol benzoate,
Estradiol valerate
Ascend Therapeutics
Estradiol,
Estradiol benzoate,
Estradiol valerate
Bayer
Dienogest,
Drospirenone,
Estradiol,
Estradiol benzoate,
Estradiol valerate,
Ethinyl estradiol,
Levomefolic acid,
Levonorgestrel
Bristol Myers Squibb
Estradiol,
Estradiol benzoate,
Estradiol valerate
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use